
Bioclop 75mg Tablet
Marketer
Caddes Life Sciences
Salt Composition
Clopidogrel (75mg)
Overview Bioclop 75mg Tablet
CardioGuard 75mg tablets are antithrombotic agents, reducing the risk of dangerous blood clot formation within blood vessels. This lowers the likelihood of stroke or myocardial infarction. A common heart-protective medication, CardioGuard 75mg is prescribed for individuals at elevated risk of cardiovascular events. This includes patients with peripheral artery disease (reduced blood flow due to vascular narrowing), recent stroke or heart attack, cardiac arrhythmias, and those who've undergone procedures like angioplasty. It's also used adjunctively with other medications to manage acute myocardial infarction and unstable angina. This medication can be ingested with or without food, consistently at the same time daily. Continuous use is crucial; discontinuation may increase stroke or heart attack risk. The most prevalent adverse effect is bleeding, manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Wound healing may be prolonged. While usually mild and self-limiting, persistent or concerning bleeding necessitates immediate medical consultation. This medication is contraindicated in individuals with active internal bleeding, such as gastric ulcers or intracranial hemorrhage. Prior to initiation, inform your physician of any bleeding disorders, recent major trauma, or upcoming surgery. Temporary discontinuation might be necessary before scheduled surgical or dental procedures.
Uses of Bioclop 75mg Tablet
Avert cardiac events and cerebrovascular accidents.
Major Benefits of Bioclop 75mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bioclop 75mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Bioclop 75mg Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Bioclop 75mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bioclop 75mg Tablets can be administered with or without food, though consistent timing is recommended.
How Bioclop 75mg Tablet works:
Platelet aggregation is inhibited by the antithrombotic agent, Bioclop 75mg Tablet. This action reduces the risk of dangerous clot development, consequently lowering the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Use of Bioclop 75mg Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Bioclop 75mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Nursing mothers can likely use Bioclop 75mg tablets without significant risk to their infants. Available human data indicate minimal danger to the baby.
DrivingSAFE
Driving ability is typically unaffected by Bioclop 75mg Tablets.
KidneySAFE IF PRESCRIBED
Bioclop 75mg tablets pose no safety concerns for patients with kidney impairment; no dosage modification is necessary.
LiverSAFE IF PRESCRIBED
Bioclop 75mg tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Bioclop 75mg Tablet :
Should you forget a Bioclop 75mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bioclop 75mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Amino acid alkyl esters |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavioral Class | ADP receptor antagonists (P2Y12 inhibitors) |
